Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and predictive significance of MYC and KRAS alterations in breast cancer from women treated with neoadjuvant chemotherapy.

PloS one - 1 Jan 2013

Pereira Cynthia Brito Lins, Leal Mariana Ferreira, de Souza Carolina Rosal Teixeira, Montenegro Raquel Carvalho, Rey Juan Antonio, Carvalho Antônio Alberto, Assumpção Paulo Pimentel, Khayat André Salim, Pinto Giovanny Rebouças, Demachki Sâmia, de Arruda Cardoso Smith Marília, Burbano Rommel Rodríguez

Abstract excerpt

Breast cancer is a complex disease, with heterogeneous clinical evolution. Several analyses have been performed to identify the risk factors for breast cancer progression and the patients who respond best to a specific treatment. We aimed to evaluate whether the hormone receptor expression, HER2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast
Share to Genes, myc

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoadjuvant Therapy

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-myc

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Receptor, ErbB-2

Source

Open in PubMed Open full text

Identifiers

PMID: 23555992
DOI: 10.1371/journal.pone.0060576
PMCID: PMC3608596

Genes

MYC
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23555992-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and predictive significance of MYC and KRAS alterations in breast cancer from women treated with neoadjuvant chemotherapy.PMID 23555992Read ↗

MYC-Driven Pathways in Breast Cancer SubtypesSemantic proximity Read ↗

Characteristics of MYC Amplification and Their Association with Clinicopathological and Molecular Factors in Patients with Breast Cancer.Semantic proximity Read ↗

Triple negative breast cancer - current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessmentSemantic proximity Read ↗

MYC in breast tumor progressionSemantic proximity Read ↗

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast CancerSemantic proximity Read ↗

c-Myc-targeted therapy in breast cancer: A review of fundamentals and pharmacological InsightsSemantic proximity Read ↗

Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcomeSemantic proximity Read ↗

Prognostic Relevance of Gene Amplifications and Coamplifications in Breast CancerSemantic proximity Read ↗

Activation of multiple cancer-associated genes at the <i>ERBB2</i> amplicon in breast cancerSemantic proximity Read ↗

Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.Semantic proximity Read ↗

Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance.Semantic proximity Read ↗

The Relevance of Common K-RAS Gene Mutations and K-RAS mRNA Expression with Clinicopathological Findings and Survival in Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.